Prediction for slrx tomorrow

**Salarius Pharmaceuticals (SLRX) is expected to experience a mixed bag of technical indicators and market sentiment**, with a forecast price range that suggests a cautious outlook.

1. **Technical Indicators**:
- The MACD is at 0.32, indicating a neutral trend.
- The RSI is at 59.52, which is near the midpoint and suggests a balanced buying and selling pressure.
- The KDJ is at 37.05, which could indicate a potential price reversal if it is below 50, and a continuation of the current trend if it is above 50.
- The 5-Day Moving Average is $3.26, and the 10-Day Moving Average is $2.68, showing a short-term upward trend.

|Ticker|Name|MACD|KDJ|RSI|Date|code|market_code|
|---|---|---|---|---|---|---|---|
|SLRX.O|Salarius||37.0499|59.5212|20240730|SLRX|185|
|SLRX.O|Salarius|0.3216|||20240731|SLRX|185|

2. **Market Sentiment**:
- The stock experienced a significant drop of 22.42% on July 31, 2024, with a closing price of $2.56.
- Over the past month, the stock has seen a positive interval percentage change of 7.56%.
- The forecast price for the next ten trading days ranges from $3.24 to $3.37, with an average of $3.29, which is slightly above the current price.

|Ticker|Name|Percentage Change|Closing Price|Date|code|market_code|
|---|---|---|---|---|---|---|
|SLRX.O|Salarius|-22.42424242424242|2.56|20240731|SLRX|185|

|Ticker|Name|Forecast Price|Date|code|market_code|
|---|---|---|---|---|---|
|SLRX.O|Salarius|3.30130374|20240731|SLRX|185|
|SLRX.O|Salarius|3.29156332|20240801|SLRX|185|
|SLRX.O|Salarius|3.24820945|20240802|SLRX|185|
|SLRX.O|Salarius|3.24294785|20240805|SLRX|185|
|SLRX.O|Salarius|3.33102626|20240806|SLRX|185|
|SLRX.O|Salarius|3.34084449|20240807|SLRX|185|
|SLRX.O|Salarius|3.34354882|20240808|SLRX|185|
|SLRX.O|Salarius|3.31294531|20240809|SLRX|185|
|SLRX.O|Salarius|3.37255062|20240812|SLRX|185|
|SLRX.O|Salarius|3.2874827|20240813|SLRX|185|

3. **Analyst Sentiment**:
- There is no available consensus rating or average price target from analysts.
- The sentiment analysis indicates that Salarius Pharmaceuticals's share price is approaching a support level, which could be a critical point for future price movements.
4. **Short Interest**:
- Short interest in SLRX has increased by 215.43% since its last report, indicating a bearish sentiment among short sellers.
- The company has 59 thousand shares sold short, which is 10.22% of all regular shares available for trading.
5. **Market Position**:
- Salarius Pharmaceuticals is a clinical-stage oncology company with a focus on developing treatments for cancers with high unmet medical need.
- The company's pipeline includes SP-3164 and seclidemstat (SP-2577), which are targeted protein degraders and inhibitors, respectively.

In conclusion, while the technical indicators suggest a potential for a slight uptick in the short term, the significant drop on the last trading day and the bearish sentiment from short sellers indicate a need for caution. The forecast prices also suggest a narrow range with an average just above the current price, which aligns with a neutral to slightly positive outlook. However, investors should monitor the stock closely for any signs of a potential reversal or a break below the support level.